<div dir="ltr"><br><div class="gmail_extra"><br><br><div class="gmail_quote">On Tue, Dec 17, 2013 at 10:38 PM, Couture Marc <span dir="ltr"><<a href="mailto:marc.couture@teluq.ca" target="_blank">marc.couture@teluq.ca</a>></span> wrote:<br>
<blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex">
<div link="blue" vlink="purple" lang="FR-CA">
<div><div class="im">
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif"">Peter Murray-Rust wrote:<u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif""><u></u> <u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif"">><u></u> <u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif"">> Proponents of CC-NC should realize that this licence directly gives a monopoly
<u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif"">> for exploitation to the publisher - the author is irrelevant<u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif"">><u></u> <u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif""><u></u> <u></u></span></p>
</div><p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif"">Not necessarily. It means that for any commercial use (and the CC definition is subject to interpration), one has to obtain the permission of the copyright owner, which may
be the author, depending of the scope of the license granted to the publisher.</span></p></div></div></blockquote><div><br></div><div>This may be true in theory, but I have never heard of an *author*, at least in scientific disciplines, issuing a take-down notice or taking an exploiter to court. Please give counterexamples if they exist.<br>
<br></div><div>The exploitation is carried out by the *publisher* through CCC Rightslink. This does not involve the author (IMO it absolutely should) - it is a monopoly business carried out by the publisher. I would be amazed if 0.1% of authors understood they had handed over effective exploitation rights to CCC+publisher. CCC Rightslink nowhere mentions authors - this is why I use the word "irrelevant" - it only mentions the publisher, even where the copyright is still held by the author. In effect the publisher is exploiting the author without involving them.<br>
<br></div><div>This exploitation only affects citizen purchasers (individuals, companies, etc.) not academics. We don't need to care about these second-class citizens.</div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex">
<div link="blue" vlink="purple" lang="FR-CA"><div><p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif""><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif""><u></u> <u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif"">I’m in the editorial board of an OA journal which uses -NC but doesn’t ask authors to grant it a license, so the authors keep the exploitation rights.<u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif""><u></u></span></p></div></div></blockquote><div><br></div><div>If you manage all permissions yourself then this may be true but I would need to see details - which Journal?. If you involve CCC RightsLink I would be very surprised if the exploitation - including pricing - was not done by the publisher without reference to individual authors.<br>
<br></div><div>And please reconsider NC. It does a lot of harm beyond the RightsLink stuff. It is not allowed by many funders and cannot be deposited in the Open Access subset of (Europe) PMC.<br></div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex">
<div link="blue" vlink="purple" lang="FR-CA"><div><p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif""> <u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif"">The problem with Elsevier is that they require (even for CC-BY) an exclusive license to publish that effectively makes them the ones who give permissions (and pocket the
money).<u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif""><u></u></span></p></div></div></blockquote><div><br></div><div>The pocketing of money is not confined to Elsevier. It is true of other TA publishers, especially those who promote CC-NC. <br>
</div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"><div link="blue" vlink="purple" lang="FR-CA"><div><p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif""> <u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif"">Marc Couture<u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif""><u></u> <u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif""><u></u> <u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(31,73,125)"><u></u> <u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(31,73,125)"><u></u> <u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(31,73,125)"><u></u> <u></u></span></p>
<div style="border-width:1pt medium medium;border-style:solid none none;border-color:rgb(181,196,223) -moz-use-text-color -moz-use-text-color;padding:3pt 0cm 0cm">
<p class="MsoNormal"><b><span style="font-size:10pt;font-family:"Tahoma","sans-serif"" lang="FR">De :</span></b><span style="font-size:10pt;font-family:"Tahoma","sans-serif"" lang="FR"> <a href="mailto:goal-bounces@eprints.org" target="_blank">goal-bounces@eprints.org</a> [mailto:<a href="mailto:goal-bounces@eprints.org" target="_blank">goal-bounces@eprints.org</a>]
<b>De la part de</b> Peter Murray-Rust<br>
<b>Envoyé :</b> 17 décembre 2013 16:04<br>
<b>À :</b> Global Open Access List (Successor of AmSci)<br>
<b>Objet :</b> [GOAL] Re: Hybrid Open Access<u></u><u></u></span></p>
</div><div><div class="h5">
<p class="MsoNormal"><u></u> <u></u></p>
<div>
<div>
<div>
<div>
<div>
<p class="MsoNormal" style="margin-bottom:12pt">I flagged this up to Elsevier about 5 months ago.
<u></u><u></u></p>
</div>
<p class="MsoNormal" style="margin-bottom:12pt">I would agree that they could be in violation of trading laws as they are asserting rights over free material and charging for it. I don't know whether the trading standards office would be able to deal with
it - we might have to make purchases.<u></u><u></u></p>
</div>
<p class="MsoNormal" style="margin-bottom:12pt">From my observations it has happened frequently with Elsevier (see my blog). I have no idea whether my examples I pointed out have been corrected.<u></u><u></u></p>
</div>
<p class="MsoNormal" style="margin-bottom:12pt">There is a more general problem in that many publishers charge for CC-NC articles. It is unclear which categories can be legitimately charged for. I note that Elsevier journals such as Cell Reports have a very
high proportion of CC-NC(-ND) on the basis that authors choose it (in the same way that 10 year olds choose burgers and sweets). I was sent an example today of an editor who was being urged by Elsevier to make her journal CC-NC. as it would protect authors.<u></u><u></u></p>
</div>
<p class="MsoNormal">Proponents of CC-NC should realize that this licence directly gives a monopoly for exploitation to the publisher - the author is irrelevant.<u></u><u></u></p>
</div>
<div>
<p class="MsoNormal" style="margin-bottom:12pt"><u></u> <u></u></p>
<div>
<p class="MsoNormal">On Tue, Dec 17, 2013 at 8:22 PM, Graham Triggs <<a href="mailto:grahamtriggs@gmail.com" target="_blank">grahamtriggs@gmail.com</a>> wrote:<u></u><u></u></p>
<div>
<p class="MsoNormal">Thanks for that Robert.<u></u><u></u></p>
<div>
<p class="MsoNormal"><u></u> <u></u></p>
</div>
<div>
<p class="MsoNormal">Interestingly, the Rightslink page also claims that the article is Copyright Elesvier. Which it isn't - the copyright is held with the authors (which is only clear when you download the PDF).<u></u><u></u></p>
</div>
<div>
<p class="MsoNormal"><u></u> <u></u></p>
</div>
<div>
<p class="MsoNormal">That means on Rightslink, aside from the licence not requiring re-use rights to be purchased, the page is making false and misleading statements about the item in question. I would say that is breaking UK law, and presumably other regions
too.<u></u><u></u></p>
</div>
<div>
<p class="MsoNormal"><u></u> <u></u></p>
</div>
<div>
<p class="MsoNormal">I would suggest that Elsevier needs to urgently review how this is advertised and/or it's relationship with CCC on the basis of that evidence.<u></u><u></u></p>
</div>
<div>
<p class="MsoNormal"><u></u> <u></u></p>
</div>
<div>
<p class="MsoNormal">Although I suspect a lot of this comes from blanket rules in place for an entire serial with CCC, and a lot of these problems could at least be mitigated by ScienceDirect:<u></u><u></u></p>
</div>
<div>
<p class="MsoNormal"><u></u> <u></u></p>
</div>
<div>
<p class="MsoNormal">a) being clear about copyright and licencing in the HTML page, as well as the PDF<u></u><u></u></p>
</div>
<div>
<p class="MsoNormal"><u></u> <u></u></p>
</div>
<div>
<p class="MsoNormal">b) not providing links to Rightslink for CC-BY articles, where this is clearly unnecessary.<u></u><u></u></p>
</div>
<div>
<p class="MsoNormal"><span style="color:rgb(136,136,136)"><u></u> <u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span style="color:rgb(136,136,136)">G<u></u><u></u></span></p>
</div>
</div>
<div>
<div>
<div>
<p class="MsoNormal" style="margin-bottom:12pt"><u></u> <u></u></p>
<div>
<p class="MsoNormal">On 17 December 2013 16:30, Kiley, Robert <<a href="mailto:r.kiley@wellcome.ac.uk" target="_blank">r.kiley@wellcome.ac.uk</a>> wrote:<u></u><u></u></p>
<div>
<div>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB">Laura</span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB"> </span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB">It is not difficult to find an example of RightLink (and probably others) quoting re-use
fees for CC-BY articles.</span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB"> </span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB">Let me give you an example.</span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB"> </span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB"><a href="http://www.sciencedirect.com/science/article/pii/S0898656813002489" target="_blank">http://www.sciencedirect.com/science/article/pii/S0898656813002489</a>
is an article funded by Wellcome, and made available under a CC-BY licence. This is made clear at ScienceDirect (albeit in a footnote).</span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB"> </span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB">However, if you follow the link to “Gets rights and content” you get redirected to the
Rightslink site where there is a form you can complete to get a quick quote for re-use. So, for arguments sake I selected that I wanted to use this single article:</span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB"> </span><span lang="EN-GB"><u></u><u></u></span></p>
<p><span style="font-size:11pt;font-family:Symbol;color:rgb(51,51,255)" lang="EN-GB">·</span><span style="font-size:7pt;color:rgb(51,51,255)" lang="EN-GB">
</span><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB">In a CD-ROM/DVD</span><span lang="EN-GB"><u></u><u></u></span></p>
<p><span style="font-size:11pt;font-family:Symbol;color:rgb(51,51,255)" lang="EN-GB">·</span><span style="font-size:7pt;color:rgb(51,51,255)" lang="EN-GB">
</span><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB">I was a pharmaceutical company</span><span lang="EN-GB"><u></u><u></u></span></p>
<p><span style="font-size:11pt;font-family:Symbol;color:rgb(51,51,255)" lang="EN-GB">·</span><span style="font-size:7pt;color:rgb(51,51,255)" lang="EN-GB">
</span><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB">I wanted to make 12000 copies</span><span lang="EN-GB"><u></u><u></u></span></p>
<p><span style="font-size:11pt;font-family:Symbol;color:rgb(51,51,255)" lang="EN-GB">·</span><span style="font-size:7pt;color:rgb(51,51,255)" lang="EN-GB">
</span><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB">And translate it into two languages</span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB"> </span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB">..and RightsLink gave me a “quick price” of
</span><span style="font-size:9pt;font-family:"Verdana","sans-serif";background:none repeat scroll 0% 0% white" lang="EN-GB">375,438.35 GBP [I love the accuracy of this price.]</span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:9pt;font-family:"Verdana","sans-serif";background:none repeat scroll 0% 0% white" lang="EN-GB"> </span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:9pt;font-family:"Verdana","sans-serif";background:none repeat scroll 0% 0% white" lang="EN-GB">Of course for a CC-BY article, there is no need for anyone to pay anything to use
this content. Attribution is all that is required.</span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:9pt;font-family:"Verdana","sans-serif";background:none repeat scroll 0% 0% white" lang="EN-GB"> </span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:9pt;font-family:"Verdana","sans-serif";background:none repeat scroll 0% 0% white" lang="EN-GB">I don’t know what would have happened if I had continued with the transaction, but
I hope that a user would not really end up getting charged.</span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:9pt;font-family:"Verdana","sans-serif";background:none repeat scroll 0% 0% white" lang="EN-GB"> </span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:9pt;font-family:"Verdana","sans-serif";background:none repeat scroll 0% 0% white" lang="EN-GB">As the CC-BY licence information is in the ScienceDirect metadata I’m not sure why
RightsLink can’t “read “ this and for whatever use the user selects, the fee is calculated to be £0.00. Better still would be for CC-BY articles NOT to contain a link to RightsLink.</span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:9pt;font-family:"Verdana","sans-serif";background:none repeat scroll 0% 0% white" lang="EN-GB"> </span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:9pt;font-family:"Verdana","sans-serif";background:none repeat scroll 0% 0% white" lang="EN-GB">Regards</span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:9pt;font-family:"Verdana","sans-serif";background:none repeat scroll 0% 0% white" lang="EN-GB">Robert</span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:9pt;font-family:"Verdana","sans-serif";background:none repeat scroll 0% 0% white" lang="EN-GB"> </span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:9pt;font-family:"Verdana","sans-serif";background:none repeat scroll 0% 0% white" lang="EN-GB"> </span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:9pt;font-family:"Verdana","sans-serif";background:none repeat scroll 0% 0% white" lang="EN-GB"> </span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><span style="font-size:11pt;font-family:"Calibri","sans-serif";color:rgb(51,51,255)" lang="EN-GB"> </span><span lang="EN-GB"><u></u><u></u></span></p>
<p class="MsoNormal"><b><span style="font-size:10pt;font-family:"Tahoma","sans-serif"" lang="EN-US">From:</span></b><span style="font-size:10pt;font-family:"Tahoma","sans-serif"" lang="EN-US">
<a href="mailto:goal-bounces@eprints.org" target="_blank">goal-bounces@eprints.org</a> [mailto:<a href="mailto:goal-bounces@eprints.org" target="_blank">goal-bounces@eprints.org</a>]
<b>On Behalf Of </b>Laura Quilter<br>
<b>Sent:</b> 17 December 2013 14:53<br>
<b>To:</b> Global Open Access List (Successor of AmSci)<br>
<b>Subject:</b> [GOAL] Re: Hybrid Open Access</span><span lang="EN-GB"><u></u><u></u></span></p>
<div>
<div>
<p class="MsoNormal"><span lang="EN-GB"> <u></u><u></u></span></p>
<div>
<p class="MsoNormal"><span lang="EN-GB">Can you clarify regarding instances of CCC RightsLink demanding payments for OA reuse? I'd really like to know details. <u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-GB"><br clear="all">
<u></u><u></u></span></p>
<div>
<div>
<p class="MsoNormal" style="margin-bottom:12pt"><span lang="EN-GB">----------------------------------<br>
Laura Markstein Quilter / <a href="mailto:lquilter@lquilter.net" target="_blank">
lquilter@lquilter.net</a><br>
<i>Attorney, Geek, Militant Librarian, Teacher<br>
</i><br>
Copyright and Information Policy Librarian<br>
University of Massachusetts, Amherst<br>
<a href="mailto:lquilter@library.umass.edu" target="_blank">lquilter@library.umass.edu</a><br>
<br>
Lecturer, Simmons College, GSLIS<br>
<a href="mailto:laura.quilter@simmons.edu" target="_blank">laura.quilter@simmons.edu</a><u></u><u></u></span></p>
</div>
</div>
<p class="MsoNormal" style="margin-bottom:12pt"><span lang="EN-GB"> <u></u><u></u></span></p>
<div>
<p class="MsoNormal"><span lang="EN-GB">On Tue, Dec 17, 2013 at 6:08 AM, Peter Murray-Rust <<a href="mailto:pm286@cam.ac.uk" target="_blank">pm286@cam.ac.uk</a>> wrote:<u></u><u></u></span></p>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<p class="MsoNormal"><span lang="EN-GB">Moving the discussion to a new title...<br>
<br>
<br>
<br>
<br>
On Tue, Dec 17, 2013 at 9:16 AM, David Prosser <<a href="mailto:david.prosser@rluk.ac.uk" target="_blank">david.prosser@rluk.ac.uk</a>> wrote:<u></u><u></u></span></p>
<div>
<p class="MsoNormal"><span lang="EN-GB"> <u></u><u></u></span></p>
<div>
<p class="MsoNormal"><span lang="EN-GB">What my paper missed and what may have been obvious at the time, but which I only saw with hindsight, were the biggest problems with the model:<u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-GB"> <u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-GB">1. There is little incentive for the publisher to set a competitive APC. It is clear that in most cases APCs for hybrids are higher than APCs for born-OA journals.
But as the hybrid is gaining the majority of its revenue from subscriptions why set a lower APC - if any author wants to pay it then it is just a bonus. Of course, this helps explains the low take-up rate for OA in most hybrid journals - why pay a hight
fee when you can get published in that journal for free? And if you really want OA then best go to a born-OA journal which is cheaper and may well be of comparable quality.<u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-GB"> <u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-GB">2. There is little pressure on the publisher to reduce subscription prices. Of course, everybody says 'we don't double dip', but this is almost impossible to
verify and from a subscriber's point of view very difficult to police. I don't know of any institution, for example, in a multi-year big deal who has received a rebate based on OA hybrid content.<u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-GB"> <u></u><u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-GB"><br clear="all">
<u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal" style="margin-bottom:12pt"><span lang="EN-GB">There are several other concerns about "hybrid":<u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-GB">* the unacceptable labelling and licensing of many TA publishers. Many hybrid papers are not identified as OA of any sort, others are labelled with confusing
words "Free content". Many do not have licences, some have incompatible rights.<u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-GB">* many are linked to RightsLink which demand payment (often huge) for Open Access reuse<u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-GB">* many deliberately use Non-BOAI compliant licences. One editor mailed me today and said the the publisher was urging them to use NC-ND as it protected authors
from exploitation.<u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal" style="margin-bottom:12pt"><span lang="EN-GB">* they are not easily discoverable. I mailed the Director of Universal Access at Elsevier asking for a complete list of OA articles and she couldn't give it to me.
I had to use some complex database query - I have no idea how reliable that was.<u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal" style="margin-bottom:12pt"><span lang="EN-GB">Leaving aside the costing of hybrid, if someone has paid for Open Access then it should be:<u></u><u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-GB">* clearly licensed on splash page, HTML, and PDFs.<u></u><u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-GB">* the XML should be available<u></u><u></u></span></p>
</div>
<p class="MsoNormal" style="margin-bottom:12pt"><span lang="EN-GB">* there should be a complete list of all OA articles from that publisher.<u></u><u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-GB">Currently I am indexing and extracting facts from PLoSONE and BMC on a daily basis. Each of these does exactly what I need:<u></u><u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-GB">* lists all new articles every day<u></u><u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-GB">* has a complete list of all articles ever published<u></u><u></u></span></p>
</div>
<p class="MsoNormal" style="margin-bottom:12pt"><span lang="EN-GB">* collaborates with scientists like me to make it easy to iterate over all the content.<u></u><u></u></span></p>
</div>
<p class="MsoNormal" style="margin-bottom:12pt"><span lang="EN-GB">It is easy to get the impression that TA publishers don't care about these issues. BMC and PLoS (and the OASPAs) do it properly - an honest product.
<u></u><u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-GB">Any publisher who wishes to be respected for their OA offerings has to do the minimum of what I list here:<u></u><u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-GB">* CC-BY<u></u><u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-GB">* list of all articles<u></u><u></u></span></p>
</div>
<p class="MsoNormal" style="margin-bottom:12pt"><span lang="EN-GB">* easy machine iteration and retrieval.<u></u><u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-GB">Anything else is holding back progress<span style="color:rgb(136,136,136)"><br clear="all">
</span><u></u><u></u></span></p>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<div>
<p class="MsoNormal"><span style="color:rgb(136,136,136)" lang="EN-GB"><br>
-- <br>
Peter Murray-Rust<br>
Reader in Molecular Informatics<br>
Unilever Centre, Dep. Of Chemistry<br>
University of Cambridge<br>
CB2 1EW, UK<br>
<a href="tel:%2B44-1223-763069" target="_blank">+44-1223-763069</a> </span><span lang="EN-GB"><u></u><u></u></span></p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<p class="MsoNormal" style="margin-bottom:12pt"><span lang="EN-GB"><br>
_______________________________________________<br>
GOAL mailing list<br>
<a href="mailto:GOAL@eprints.org" target="_blank">GOAL@eprints.org</a><br>
<a href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal" target="_blank">http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</a><u></u><u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-GB"> <u></u><u></u></span></p>
</div>
</div>
</div>
</div>
<p class="MsoNormal" style="margin-bottom:12pt"><span lang="EN-GB"><u></u> <u></u></span></p>
<p style="text-align:center" align="center"><span lang="EN-GB">This message has been scanned for viruses by
<a href="http://www.blackspider.com/" target="_blank"><span style>BlackSpider MailControl</span></a><u></u><u></u></span></p>
</div>
<p class="MsoNormal" style="margin-bottom:12pt"><br>
_______________________________________________<br>
GOAL mailing list<br>
<a href="mailto:GOAL@eprints.org" target="_blank">GOAL@eprints.org</a><br>
<a href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal" target="_blank">http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</a><u></u><u></u></p>
</div>
<p class="MsoNormal"><u></u> <u></u></p>
</div>
</div>
</div>
<p class="MsoNormal" style="margin-bottom:12pt"><br>
_______________________________________________<br>
GOAL mailing list<br>
<a href="mailto:GOAL@eprints.org" target="_blank">GOAL@eprints.org</a><br>
<a href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal" target="_blank">http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</a><u></u><u></u></p>
</div>
<p class="MsoNormal"><br>
<br clear="all">
<br>
-- <br>
Peter Murray-Rust<br>
Reader in Molecular Informatics<br>
Unilever Centre, Dep. Of Chemistry<br>
University of Cambridge<br>
CB2 1EW, UK<br>
<a href="tel:%2B44-1223-763069" value="+441223763069" target="_blank">+44-1223-763069</a> <u></u><u></u></p>
</div>
</div></div></div>
</div>
<br>_______________________________________________<br>
GOAL mailing list<br>
<a href="mailto:GOAL@eprints.org">GOAL@eprints.org</a><br>
<a href="http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal" target="_blank">http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal</a><br>
<br></blockquote></div><br><br clear="all"><br>-- <br>Peter Murray-Rust<br>Reader in Molecular Informatics<br>Unilever Centre, Dep. Of Chemistry<br>University of Cambridge<br>CB2 1EW, UK<br>+44-1223-763069
</div></div>